John Ballantyne

Investor profile

John Ballantyne

Angel, Operator angel

Fargo·North Dakota·United States11known investments

John Ballantyne is an angel investor and operator angel based in Fargo, North Dakota, United States. The known portfolio counts 11 companies: Kytopen, Elegen, Cytonus Therapeutics, Myosana Therapeutics, GlucoTrack, Thrixen, VerImmune, CureLab Oncology, Curelab Veterinary, JURA Bio and SmartWorx.

Is John Ballantyne a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

joh***@***.comLinkedIn profile on fileAvailable after registration.
Get contact

John Ballantyne portfolio companies (11)

  • Kytopen
  • Elegen
  • Cytonus Therapeutics
  • Myosana Therapeutics
  • GlucoTrack
  • Thrixen
  • VerImmune
  • CureLab Oncology
  • Curelab Veterinary
  • JURA Bio
  • SmartWorx

Investor Profile

Founders in the listed sector Healthcare, and focus areas Biopharma, Biotech, Drug Discovery and Genomics will recognize the pattern in this portfolio.

Stage-wise, the known deals cluster around Pre-Seed, Seed and Series A rounds.

Reviewing the investment history helps decide whether there is a realistic fit before reaching out.

Similar investors

Showing 20 of 98

Frequently asked questions

Who is John Ballantyne?

John Ballantyne is an angel investor and operator angel based in Fargo, North Dakota, United States with 11 known investments on file, among them Kytopen, Elegen and Cytonus Therapeutics. The sections above list the sectors and stages attached to that record.

What does John Ballantyne invest in?

Listed sectors include Healthcare; listed focus areas include Biopharma, Biotech, Drug Discovery and Genomics. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does John Ballantyne invest at?

The known deals of John Ballantyne include Pre-Seed, Seed and Series A rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

How do I contact John Ballantyne?

An email address and a LinkedIn page are on file for John Ballantyne. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal